ELIZABETH INSCOE: Open Payments
NPI 1538785134 · ROANOKE RAPIDS, NC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$496 in 23 payments from 13 companies in 2025. Trend: 2023 $112 · 2024 $269 · 2025 $496
Food & beverage: $496
| Company | Payments | Amount |
|---|---|---|
| Merck Sharp & Dohme LLC | 4 | $79 |
| Bayer Healthcare Pharmaceuticals Inc. | 3 | $56 |
| Pharmacosmos Therapeutics Inc. | 2 | $53 |
| Novartis Pharmaceuticals Corporation | 2 | $48 |
| Eisai Inc. | 2 | $48 |
| ARRAY BIOPHARMA INC | 2 | $42 |
| GlaxoSmithKline, LLC. | 2 | $39 |
| PharmaEssentia USA Corporation | 1 | $28 |
| Gilead Sciences, Inc. | 1 | $24 |
| Tempus AI, Inc | 1 | $24 |
Products named: KEYTRUDA, Nubeqa, MONOFERRIC, Lenvima, PLUVICTO, BESREMI, Trodelvy, XT CDX.
Industry payments across NC — which companies pay providers there.
